“Merck and Schering-Plough must pay $688 million for lying to shareholders about the benefits of cholesterol drug Vytorin over its cheaper, generic version”
$688 Million Settlement Approved in Merck Case By ROSE BOUBOUSHIAN (CN) - Merck and Schering-Plough must pay $688 million for lying to shareholders about the benefits of cholesterol drug Vytorin…
You must be logged in to post a comment.